AAOS Now / Issue
Arun Aneja, MD, PhD; Jonathan Grabau, MD
Following FDA approval, any marketing or promotion of a given medications, biologics, and devices (MBD) is strictly restricted to the approved indication. Discretion on how to use devices on the market for patients is the responsibility of clinicians.
Some AAOS Now articles are available only to AAOS members. Please log in to access this article.
Not a member? Become a member.